|
1
|
Awad MM, Calkins H and Judge DP:
Mechanisms of disease: Molecular genetics of arrhythmogenic right
ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc
Med. 5:258–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalal D, Nasir K, Bomma C, Prakasa K,
Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, et
al: Arrhythmogenic right ventricular dysplasia: A United States
experience. Circulation. 112:3823–3832. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fressart V, Duthoit G, Donal E, Probst V,
Deharo JC, Chevalier P, Klug D, Dubourg O, Delacretaz E, Cosnay P,
et al: Desmosomal gene analysis in arrhythmogenic right ventricular
dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact
in practice. Europace. 12:861–868. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saffitz JE: Arrhythmogenic cardiomyopathy
and abnormalities of cell-to-cell coupling. Heart Rhythm. 6(8
Suppl): S62–S65. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beffagna G, Occhi G, Nava A, Vitiello L,
Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, et al:
Regulatory mutations in transforming growth factor-beta3 gene cause
arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc
Res. 65:366–373. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Merner ND, Hodgkinson KA, Haywood AF,
Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K,
Thierfelder L, McKenna W, et al: Arrhythmogenic right ventricular
cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic
disorder caused by a missense mutation in the TMEM43 gene. Am J Hum
Genet. 82:809–821. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tiso N, Stephan DA, Nava A, Bagattin A,
Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B,
et al: Identification of mutations in the cardiac ryanodine
receptor gene in families affected with arrhythmogenic right
ventricular cardiomyopathy type 2 (arvd2). Hum Mol Genet.
10:189–194. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Tintelen JP, Van Gelder IC, Asimaki A,
Suurmeijer AJ, Wiesfeld AC, Jongbloed JD, van den Wijngaard A, Kuks
JB, van Spaendonck-Zwarts KY, Notermans N, et al: Severe cardiac
phenotype with right ventricular predominance in a large cohort of
patients with a single missense mutation in the des gene. Heart
Rhythm. 6:1574–1583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taylor M, Graw S, Sinagra G, Barnes C,
Slavov D, Brun F, Pinamonti B, Salcedo EE, Sauer W, Pyxaras S, et
al: Genetic variation in titin in arrhythmogenic right ventricular
cardiomyopathy-overlap syndromes. Circulation. 124:876–885. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bauce B, Nava A, Beffagna G, Basso C,
Lorenzon A, Smaniotto G, De Bortoli M, Rigato I, Mazzotti E,
Steriotis A, et al: Multiple mutations in desmosomal proteins
encoding genes in arrhythmogenic right ventricular
cardiomyopathy/dysplasia. Heart Rhythm. 7:22–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lorenzon A, Beffagna G, Bauce B, De
Bortoli M, Li Mura IE, Calore M, Dazzo E, Basso C, Nava A, Thiene G
and Rampazzo A: Desmin mutations and arrhythmogenic right
ventricular cardiomyopathy. Am J Cardiol. 111:400–405. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasmussen TB, Hansen J, Nissen PH,
Palmfeldt J, Dalager S, Jensen UB, Kim WY, Heickendorff L, Mølgaard
H, Jensen HK, et al: Protein expression studies of desmoplakin
mutations in cardiomyopathy patients reveal different molecular
disease mechanisms. Clin Genet. 84:20–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rasmussen TB, Palmfeldt J, Nissen PH,
Magnoni R, Dalager S, Jensen UB, Kim WY, Heickendorff L, Mølgaard
H, Jensen HK, et al: Mutated desmoglein-2 proteins are incorporated
into desmosomes and exhibit dominant-negative effects in
arrhythmogenic right ventricular cardiomyopathy. Hum Mutat.
34:697–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang WC, Tian X, Yuo CY, Chen WZ, Kan TM,
Su YN, Nishino I, Wong LC and Jong YJ: Comprehensive target
capture/next-generation sequencing as a second-tier diagnostic
approach for congenital muscular dystrophy in Taiwan. PLoS One.
12:e01705172017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang B, Chen Y, Xu B, Hong N, Liu R, Qi M
and Shen L: Identification of a novel missense mutation of MIP in a
Chinese family with congenital cataracts by target region capture
sequencing. Sci Rep. 7:401292017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyanaga A, Masuda M, Tsuta K, Kawasaki K,
Nakamura Y, Sakuma T, Asamura H, Gemma A and Yamada T: Hippo
pathway gene mutations in malignant mesothelioma: Revealed by RNA
and targeted exon sequencing. J Thorac Oncol. 10:844–851. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kinnear C, Glanzmann B, Banda E,
Schlechter N, Durrheim G, Neethling A, Nel E, Schoeman M, Johnson G
and van Helden PD: Exome sequencing identifies a novel TTC37
mutation in the first reported case of Trichohepatoenteric syndrome
(THE-S) in South Africa. BMC Med Genet. 18:262017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frank R, Fontaine G, Vedel J, Mialet G,
Sol C, Guiraudon G and Grosgogeat Y: Electrocardiology of 4 cases
of right ventricular dysplasia inducing arrhythmia. Arch Mal Coeur
Vaiss. 71:963–972. 1978.(In French). PubMed/NCBI
|
|
19
|
Basso C, Corrado D, Marcus FI, Nava A and
Thiene G: Arrhythmogenic right ventricular cardiomyopathy. Lancet.
373:1289–1300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Campuzano O, Alcalde M, Allegue C,
Iglesias A, García-Pavía P, Partemi S, Oliva A, Pascali VL, Berne
P, Sarquella-Brugada G, et al: Genetics of arrhythmogenic right
ventricular cardiomyopathy. J Med Genet. 50:280–289. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van der Zwaag PA, Jongbloed JD, van den
Berg MP, van der Smagt JJ, Jongbloed R, Bikker H, Hofstra RM and
van Tintelen JP: A genetic variants database for arrhythmogenic
right ventricular dysplasia/cardiomyopathy. Hum Mutat.
30:1278–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kapplinger JD, Landstrom AP, Salisbury BA,
Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H,
Wiesfeld AC, et al: Distinguishing arrhythmogenic right ventricular
cardiomyopathy/dysplasia-associated mutations from background
genetic noise. J Am Coll Cardiol. 57:2317–2327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murray B: Arrhythmogenic right ventricular
dysplasia/cardiomyopathy (ARVD/C): A review of molecular and
clinical literature. J Genet Couns. 21:494–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Towbin JA: Arrhythmogenic right
ventricular cardiomyopathy: A paradigm of overlapping disorders.
Ann Noninvasive Electrocardiol. 13:325–326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sen-Chowdhry S, Syrris P, Pantazis A,
Quarta G, McKenna WJ and Chambers JC: Mutational heterogeneity,
modifier genes and environmental influences contribute to
phenotypic diversity of arrhythmogenic cardiomyopathy. Circ
Cardiovasc Genet. 3:323–330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Calkins H: Arrhythmogenic right
ventricular dysplasia. Curr Probl Cardiol. 38:103–123. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gerull B, Heuser A, Wichter T, Paul M,
Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT,
MacRae CA, et al: Mutations in the desmosomal protein plakophilin-2
are common in arrhythmogenic right ventricular cardiomyopathy. Nat
Genet. 36:1162–1164. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu X, Liu W, Hu D, Zhu T, Li C, Li L, Guo
C, Liu X, Wang L, Zheng H, et al: Mutations of plakophilin-2 in
Chinese with arrhythmogenic right ventricular
dysplasia/cardiomyopathy. Am J Cardiol. 103:1439–1444. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu SL, Wang PN, Hou YS, Zhang XC, Shan ZX,
Yu XY and Deng M: Mutation of plakophilin-2 gene in arrhythmogenic
right ventricular cardiomyopathy. Chin Med J (Engl). 122:403–407.
2009.PubMed/NCBI
|
|
30
|
Bao J, Wang J, Yao Y, Wang Y, Fan X, Sun
K, He DS, Marcus FI, Zhang S, Hui R, et al: Correlation of
ventricular arrhythmias with genotype in arrhythmogenic right
ventricular cardiomyopathy. Circ Cardiovasc Genet. 6:552–556. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Joshi-Mukherjee R, Coombs W, Musa H,
Oxford E, Taffet S and Delmar M: Characterization of the molecular
phenotype of two arrhythmogenic right ventricular cardiomyopathy
(arvc)-related plakophilin-2 (pkp2) mutations. Heart Rhythm.
5:1715–1723. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hall C, Li S, Li H, Creason V and Wahl JK
III: Arrhythmogenic right ventricular cardiomyopathy plakophilin-2
mutations disrupt desmosome assembly and stability. Cell Commun
Adhes. 16:15–27. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kirchner F, Schuetz A, Boldt LH, Martens
K, Dittmar G, Haverkamp W, Thierfelder L, Heinemann U and Gerull B:
Molecular insights into arrhythmogenic right ventricular
cardiomyopathy caused by plakophilin-2 missense mutations. Circ
Cardiovasc Genet. 5:400–411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato PY, Musa H, Coombs W, Guerrero-Serna
G, Patino GA, Taffet SM, Isom LL and Delmar M: Loss of
plakophilin-2 expression leads to decreased sodium current and
slower conduction velocity in cultured cardiac myocytes. Circ Res.
105:523–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
